Since myeloma cells are neoplastic plasma cells which make monoclonal immunoglobulins, we detected the serum IgA levels at day 14, 28, and 42 to explore whether Reelin can inhibit the production of this monoclonal protein, thus suppressing the pathologic effects of MM. This evidence concerns the gene CD79A and Miyoshi myopathy.